Open access
Open access
Powered by Google Translator Translator

Infectious Diseases (all articles)

Meta-analysis: Utility of Broad-spectrum Antibiotics for Diagnosing Pulmonary Tuberculosis in Adults

20 May, 2020 | 09:44h | UTC

Utility of broad-spectrum antibiotics for diagnosing pulmonary tuberculosis in adults: a systematic review and meta-analysis – The Lancet Infectious Diseases

Commentary: The uncertainty of tuberculosis diagnosis – The Lancet Infectious Diseases

 


Should Azithromycin be Used to Treat COVID-19?

20 May, 2020 | 09:47h | UTC

Should azithromycin be used to treat COVID-19? A rapid review – BJGP Open

 


Covid-19 Case Series: Acute Heart Failure in Multisystem Inflammatory Syndrome in Children

19 May, 2020 | 04:37h | UTC

Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic – Circulation

Related Case Report: Cardiac dysfunction and thrombocytopenia-associated multiple organ failure inflammation phenotype in a severe paediatric case of COVID-19 – The Lancet Child & Adolescent Health

 

Related Commentary on Twitter

 


Viewpoint: Accelerating COVID-19 Therapeutic Interventions and Vaccines

19 May, 2020 | 04:31h | UTC

Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): An Unprecedented Partnership for Unprecedented Times – JAMA

Commentary: NIH Director: Defeating COVID-19 requires unprecedented action and collaboration – National Institutes of Health

Related Viewpoint: Planning for a COVID-19 Vaccination Program – JAMA

 


Seroprevalence of SARS-CoV-2–Specific Antibodies Among Adults in Los Angeles County, California

19 May, 2020 | 04:34h | UTC

Seroprevalence of SARS-CoV-2–Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020 – JAMA

“the prevalence of antibodies to SARS-CoV-2 was 4.65%. The estimate implies that approximately 367 000 adults had SARS-CoV-2 antibodies, which is substantially greater than the 8430 cumulative number of confirmed infections in the county on April 10”

 


Cross-neutralization of SARS-CoV-2 by a Human Monoclonal SARS-CoV Antibody

19 May, 2020 | 04:35h | UTC

Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody – Nature

Commentary: Cross-neutralization of SARS and COVID-19 coronaviruses by a monoclonal antibody – News Medical

 


[No Publication Available] Hamster Research Shows Effectiveness of Masks ‘Huge’ in Covid-19 Battle

19 May, 2020 | 04:30h | UTC

Coronavirus: hamster research shows effectiveness of masks ‘huge’ in Covid-19 battle, Hong Kong scientists say – South China Morning Post

 


Decline in Child Vaccination Coverage During the COVID-19 Pandemic

19 May, 2020 | 04:26h | UTC

Decline in Child Vaccination Coverage During the COVID-19 Pandemic — Michigan Care Improvement Registry, May 2016–May 2020 – CDC Morbidity and Mortality Weekly Report

Commentaries: More evidence US childhood vaccinations are dropping amid coronavirus pandemic – CNN AND Michigan reports a sharp drop in child vaccinations after the CDC warned missed shots could lead to a measles resurgence across the US – Business Insider

 


SARS-CoV-2 Transmission from Presymptomatic Meeting Attendee, Germany

19 May, 2020 | 04:22h | UTC

SARS-CoV-2 Transmission from Presymptomatic Meeting Attendee, Germany – CDC Emerging Infectious Diseases

 


Infectious SARS-CoV-2 in Feces of Patient with Severe COVID-19

19 May, 2020 | 04:24h | UTC

Infectious SARS-CoV-2 in Feces of Patient with Severe COVID-19 – CDC Emerging Infectious Diseases

 


Early Data Show Moderna Covid-19 Vaccine Generates Immune Response

19 May, 2020 | 04:29h | UTC

Early data show Moderna Covid-19 vaccine generates immune response – STAT

See also: Moderna Coronavirus Vaccine Trial Shows Promising Early Results – The New York Times AND Expert reaction to Moderna announcement about their phase 1 trial data on their mRNA vaccine (mRNA-1273) candidate against COVID-19 – Science Media Centre

 


Infection of Dogs with SARS-CoV-2

19 May, 2020 | 04:19h | UTC

Infection of dogs with SARS-CoV-2 -Nature

Commentary: Coronavirus in cats and dogs: How does COVID-19 impact pets? – CNet

 


Randomized Trial: No Benefit from Hydroxychloroquine in Patients with Mild to Moderate Covid-19

18 May, 2020 | 02:11h | UTC

Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial – The BMJ

Commentary: Further evidence does not support hydroxychloroquine for patients with COVID-19 – BMJ

 


Clinical Practice: Severe Covid-19

18 May, 2020 | 02:09h | UTC

Severe Covid-19 – New England Journal of Medicine

 


Hemostasis Disorders in Critically Ill Patients with COVID-19

18 May, 2020 | 02:08h | UTC

Understanding pathophysiology of hemostasis disorders in critically ill patients with COVID-19 – Intensive Care Medicine

 

Related Commentary on Twitter

 


LDH, Lymphocyte Count, and C-reactive protein can Predict Mortality in Covid-19

18 May, 2020 | 01:58h | UTC

An interpretable mortality prediction model for COVID-19 patients – Nature Machine Learning

 

Related Commentary on Twitter

 


Clinical and Chest Radiography Features Determine Patient Outcomes In COVID-19

18 May, 2020 | 01:59h | UTC

Clinical and Chest Radiography Features Determine Patient Outcomes In Young and Middle Age Adults with COVID-19 – Radiology

 


Risk Factors for SARS-CoV-2 in Patients with Symptoms

18 May, 2020 | 01:55h | UTC

Assessing risk factors for SARS-CoV-2 infection in patients presenting with symptoms in Shanghai, China: a multicentre, observational cohort study – Lancet Digital Health

 


Risk factors for SARS-CoV-2 in a Primary Care Network

18 May, 2020 | 01:56h | UTC

Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study – The Lancet Infectious Diseases

Commentaries: Who is most likely to be infected with SARS-CoV-2? – The Lancet Infectious Diseases AND Sociodemographic factors associated with a positive test for COVID-19 in primary care – The Lancet AND COVID-19 discriminates along racial, socioeconomic lines, study finds – UPI

 


Quantifying the Impact of Interventions in COVID-19 Pandemic

18 May, 2020 | 01:50h | UTC

Quantifying the impact of interventions in COVID-19 pandemic – Max Planck Institute for Dynamics and Self-Organization

Original Study: Inferring change points in the spread of COVID-19 reveals the effectiveness of interventions – Science

 


Systematic Review: Risks and Impact of ACE Inhibitors or ARBs on SARS-CoV-2 Infection in Adults

18 May, 2020 | 01:47h | UTC

Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults: A Living Systematic Review – Annals of Internal Medicine

Editorial: COVID-19 and Angiotensin-Converting Enzyme Inhibitor/Angiotensin-Receptor Blocker Therapy – Annals of Internal Medicine

 


Wrong but Useful — What Covid-19 Epidemiologic Models Can and Cannot Tell Us

18 May, 2020 | 01:48h | UTC

Wrong but Useful — What Covid-19 Epidemiologic Models Can and Cannot Tell Us – New England Journal of Medicine

Related: Modelling the pandemic – The BMJ AND Predictive Mathematical Models of the COVID-19 Pandemic (several commentaries on the subject)

 


Study: Use of Renin–angiotensin–aldosterone System Inhibitors Does Not Increase the Risk of COVID-19 Requiring Admission to Hospital

18 May, 2020 | 01:45h | UTC

Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study – The Lancet

Commentary: Hypertension, renin–angiotensin–aldosterone system inhibition, and COVID-19 – The Lancet

 


[Preprint] Early Safety Indicators of COVID-19 Convalescent Plasma in 5,000 Patients

15 May, 2020 | 03:50h | UTC

Early Safety Indicators of COVID-19 Convalescent Plasma in 5,000 Patients – medRxiv

Commentary: Convalescent plasma is safe to treat COVID-19: nationwide study – NBC News

 


Description of an Outbreak of Severe Kawasaki-like Disease at the Italian Epicenter of the SARS-CoV-2 Epidemic

15 May, 2020 | 03:53h | UTC

An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study – The Lancet

Commentaries: Kawasaki-like disease: emerging complication during the COVID-19 pandemic – The Lancet AND Kawasaki-like COVID-19 complication found in Italian kids – CIDRAP AND What we know about the new Covid-19-linked illness in children – Vox AND Coronavirus: Children affected by rare Kawasaki-like disease – BBC

Related: Case Series: Hyperinflammatory Shock in Children During COVID-19 Pandemic

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.